Logos Capital is a San Francisco based venture capital firm investing in biotechnology-based startups. The company seeks to invest in in-house medical data analytics with scientific and clinical expertise to identify transformative therapies in life sciences and healthcare. It focuses on companies involved in new technologies and therapeutic approaches in molecular biology, bioinformatics, and genetic engineering, working towards our understanding of medicine and disease biology. Founded in 2019, the company has made four investments.
Nkarta Therapeutics is a biotechnology company using natural killer (NK) immune cells for cellular therapies.
ALX Oncology is a Burlingame, California-based biotechnology company working on pre-clinical stage immuno-oncology therapies.
Associated investment funds
Arsani William, MD MBA
Chief Investment Officer
Chief Operating Officer
Edward Zhong, PhD
Head of Data Science
Graham Walmsley, MD PhD
Chief Financial Officer & Chief Compliance Officer
Yanni Souroutzidis, MBA
Head of Research
Documentaries, videos and podcasts
- BiotechnologyBiotechnology can refer to the application of science and technology to living organisms or the use of living organisms, their parts, products or models thereof to solve a problem, produce knowledge or produce goods and services. Biotechnology may involve the alteration of living or non-living materials.